Journal of Clinical Endocrinology & Metabolism, Vol 71, 164-169, Copyright © 1990 by Endocrine Society

ARTICLES

Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction

F Barbetti, N Raben, T Kadowaki, A Cama, D Accili, KH Gabbay, JA Merenich, SI Taylor and J Roth
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Mutations in the insulin gene can impair the bioactivity of the insulin molecule. Previously, two classes of mutations have been identified: 1) those that impair posttranslational processing of proinsulin to insulin, and 2) those that alter the structure of the insulin molecule, thereby reducing the affinity of the molecule for the insulin receptor. We have investigated two apparently unrelated patients, both of which have mutations that inhibit the conversion of proinsulin to insulin. By directly sequencing genomic DNA amplified by polymerase chain reaction, we have demonstrated that both patients are heterozygous for the same point mutation converting codon 65 from an arginine (CGT) to a histidine (CAT) codon. Because Arg65 is one of the two dibasic amino acids at the site of proteolytic cleavage between the insulin A-chain and C-peptide, this mutation explains the impairment in the cleavage of proinsulin to insulin. Interestingly, the same His65 mutation has been identified in the insulin gene of a Japanese kindred with familial hyperproinsulinemia. Thus, this mutation has occurred in three apparently unrelated kindreds from two different racial groups. This observation is consistent with the hypothesis that the dinucleotide sequence CpG, the first two nucleotides in the arginine (CGT) codon, is a "hot spot" for mutations.

This article has been cited by other articles:

				K. Vandenborne, S. A Roelens, V. M Darras, E. R Kuhn, and S. Van der Geyten Cloning and hypothalamic distribution of the chicken thyrotropin-releasing hormone precursor cDNA J. Endocrinol., August 1, 2005; 186(2): 387 - 396. [Abstract] [Full Text] [PDF]

				S. Dhanvantari, F.-S. Shen, T. Adams, C. R. Snell, C. Zhang, R. B. Mackin, S. J. Morris, and Y. P. Loh Disruption of a Receptor-Mediated Mechanism for Intracellular Sorting of Proinsulin in Familial Hyperproinsulinemia Mol. Endocrinol., September 1, 2003; 17(9): 1856 - 1867. [Abstract] [Full Text] [PDF]

				J. McElver, D. Patton, M. Rumbaugh, C.-m. Liu, L. J. Yang, and D. Meinke The TITAN5 Gene of Arabidopsis Encodes a Protein Related to the ADP Ribosylation Factor Family of GTP Binding Proteins PLANT CELL, August 1, 2000; 12(8): 1379 - 1392. [Abstract] [Full Text]

				M. Deberg, P. Houssa, B. H. Frank, F. Sodoyez-Goffaux, and J.-C. Sodoyez Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors Clin. Chem., July 1, 1998; 44(7): 1504 - 1513. [Abstract] [Full Text] [PDF]

				P. Houssa, B. Dinesen, M. Deberg, B. H. Frank, C. Van Schravendijk, F. Sodoyez-Goffaux, and J.-C. Sodoyez First direct assay for intact human proinsulin Clin. Chem., July 1, 1998; 44(7): 1514 - 1519. [Abstract] [Full Text] [PDF]

				M. G. Warren-Perry, S. E. Manley, D. Ostrega, K. Polonsky, S. Mussett, P. Brown, and R. C. Turner A Novel Point Mutation in the Insulin Gene Giving Rise to Hyperproinsulinemia J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1629 - 1631. [Abstract] [Full Text] [PDF]